Find Research outputs

Search results

• A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf

  Sutor, S. L., Vroman, B. T., Armstrong, E. A., Abraham, R. T. & Karnitz, L. M., Mar 12 1999, In: Journal of Biological Chemistry. 274, 11, p. 7002-7010 9 p.

  Research output: Contribution to journal › Article › peer-review
  65 Scopus citations

• A Phorbol Ester‐Sensitive Kinase Catalyzes the Phosphorylation of P₀ Glycoprotein in Myelin

  Brunden, K. R. & Poduslo, J. F., Dec 1987, In: Journal of neurochemistry. 49, 6, p. 1863-1872 10 p.

  Research output: Contribution to journal › Article › peer-review
  29 Scopus citations

• A phoenix rising: Who considers herself a "survivor" after a diagnosis of breast cancer?

  Jagielski, C. H., Hawley, S. T., Corbin, K., Weiss, M. C. & Griggs, J. J., Dec 2012, In: Journal of Cancer Survivorship. 6, 4, p. 451-457 7 p.

  Research output: Contribution to journal › Article › peer-review

• Aphidicolin-induced FRA3B breakpoints cluster in two distinct regions

  Wang, L., Paradee, W., Mullins, C., Shridhar, R., Rosati, R., Wilke, C. M., Glover, T. W. & Smith, D. I., May 1 1997, In: Genomics. 41, 3, p. 485-488 4 p.

  Research output: Contribution to journal › Article › peer-review
  48 Scopus citations

• Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: The need to optimize instrument setting and define a lymphocyte collection target

  Katipamula, R., Porrata, L. F., Gastineau, D. A., Markovic, S. N., Moore, S. B., Greiner, C., Burgstaler, E. A., Padley, D. J. & Winters, J. L., May 2006, In: Bone Marrow Transplantation. 37, 9, p. 811-817 7 p.

  Research output: Contribution to journal › Article › peer-review
  12 Scopus citations

• A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome

  Bains, S., Dotzler, S. M., Krijger, C., Giudicessi, J. R., Ye, D., Bikker, H., Rohatgi, R. K., Tester, D. J., Bos, J. M., Wilde, A. A. M. & Ackerman, M. J., Mar 2022, In: Heart rhythm. 19, 3, p. 435-442 8 p.

  Research output: Contribution to journal › Article › peer-review

• A phenotype-based forward genetic screen identifies Dnajb6 as a sick sinus syndrome gene

  Ding, Y., Lang, D., Yan, J., Bu, H., Li, H., Jiao, K., Yang, J., Ni, H., Morotti, S., Le, T., Clark, K. J., Port, J., Ekker, S. C., Cao, H., Zhang, Y., Wang, J., Grandi, E., Li, Z., Shi, Y., Li, Y., & 2 othersGlukhov, A. V. & Xu, X., 2022, In: eLife. 11, e77327.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR

  Safarova, M. S., Satterfield, B. A., Fan, X., Austin, E. E., Ye, Z., Bastarache, L., Zheng, N., Ritchie, M. D., Borthwick, K. M., Williams, M. S., Larson, E. B., Scrol, A., Jarvik, G. P., Crosslin, D. R., Leppig, K., Rasmussen-Torvik, L. J., Pendergrass, S. A., Sturm, A. C., Namjou, B., Shah, A. S., & 12 othersCarroll, R. J., Chung, W. K., Wei, W. Q., Feng, Q. P., Stein, C. M., Roden, D. M., Manolio, T. A., Schaid, D. J., Denny, J. C., Hebbring, S. J., de Andrade, M. & Kullo, I. J., Dec 1 2019, In: npj Genomic Medicine. 4, 1, 3.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  7 Scopus citations

• Aphasia with left occipitotemporal hypometabolism: A novel presentation of posterior cortical atrophy?

  Wicklund, M. R., Duffy, J. R., Strand, E. A., Whitwell, J. L., MacHulda, M. M. & Josephs, K. A., Sep 2013, In: Journal of Clinical Neuroscience. 20, 9, p. 1237-1240 4 p.

  Research output: Contribution to journal › Article › peer-review
  8 Scopus citations

• A phase i trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies

  Chow, L. Q. M., Jonker, D. I., Dy, G. K., Nicholas, G., Fortin, C., Patricia, D., Adjei, A. A., Belani, C. P., Gupta, A., Park, J. S., Zhang, S., Sbar, E. I. & Laurie, S. A., May 2013, In: Cancer chemotherapy and pharmacology. 71, 5, p. 1273-1285 13 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

  Muscal, J. A., Thompson, P. A., Horton, T. M., Ingle, A. M., Ahern, C. H., McGovern, R. M., Reid, J. M., Ames, M. M., Espinoza-Delgado, I., Weigel, B. J. & Blaney, S. M., Mar 2013, In: Pediatric Blood and Cancer. 60, 3, p. 390-395 6 p.

  Research output: Contribution to journal › Article › peer-review
  50 Scopus citations

• A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2

  Holkova, B., Supko, J. G., Ames, M. M., Reid, J. M., Shapiro, G. I., Perkins, E. B., Ramakrishnan, V., Tombes, M. B., Honeycutt, C., McGovern, R. M., Kmieciak, M., Shrader, E., Wellons, M. D., Sankala, H., Doyle, A., Wright, J., Roberts, J. D. & Grant, S., Apr 1 2013, In: Clinical Cancer Research. 19, 7, p. 1873-1883 11 p.

  Research output: Contribution to journal › Article › peer-review
  22 Scopus citations

• A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer

  Nowakowski, G. S., McCollum, A. K., Ames, M. M., Mandrekar, S. J., Reid, J. M., Adjei, A. A., Toft, D. O., Safgren, S. L. & Erlichman, C., Oct 15 2006, In: Clinical Cancer Research. 12, 20 PART 1, p. 6087-6093 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  101 Scopus citations

• A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer

  Kim, R., Tan, E., Wang, E., Mahipal, A., Chen, D. T., Cao, B., Masawi, F., Machado, C., Yu, J. & Kim, D. W., Dec 2020, In: Oncologist. 25, 12, p. e1893-e1899

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer

  Dy, G. K., Bruzek, L. M., Croghan, G. A., Mandrekar, S., Erlichman, C., Peethambaram, P., Pitot, H. C., Hanson, L. J., Reid, J. M., Furth, A., Cheng, S., Martell, R. E., Kaufmann, S. H. & Adjei, A. A., Mar 1 2005, In: Clinical Cancer Research. 11, 5, p. 1877-1883 7 p.

  Research output: Contribution to journal › Article › peer-review
  31 Scopus citations

• A phase i trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer

  Ma, C. X., Suman, V. J., Goetz, M., Haluska, P., Moynihan, T., Nanda, R., Olopade, O., Pluard, T., Guo, Z., Chen, H. X., Erlichman, C., Ellis, M. J. & Fleming, G. F., May 2013, In: Breast Cancer Research and Treatment. 139, 1, p. 145-153 9 p.

  Research output: Contribution to journal › Article › peer-review
  48 Scopus citations

• A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)

  Ravandi, F., Gojo, I., Patnaik, M. M., Minden, M. D., Kantarjian, H., Johnson-Levonas, A. O., Fancourt, C., Lam, R., Jones, M. B., Knox, C. D., Rose, S., Patel, P. S. & Tibes, R., Sep 1 2016, In: Leukemia Research. 48, p. 92-100 9 p.

  Research output: Contribution to journal › Article › peer-review
  18 Scopus citations

• A phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity

  Adjei, A. A., Erlichman, C., Davis, J. N., Cutler, D. L., Sloan, J. A., Marks, R. S., Hanson, L. J., Svingen, P. A., Atherton, P., Bishop, W. R., Kirschmeier, P. & Kaufmann, S. H., Apr 1 2000, In: Cancer research. 60, 7, p. 1871-1877 7 p.

  Research output: Contribution to journal › Article › peer-review
  250 Scopus citations

• A phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

  Adjei, A. A., Croghan, G. A., Erlichman, C., Marks, R. S., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Bruzek, L. M., Atherton, P., Thibault, A., Palmer, P. A. & Kaufmann, S. H., Jul 1 2003, In: Clinical Cancer Research. 9, 7, p. 2520-2526 7 p.

  Research output: Contribution to journal › Article › peer-review
  48 Scopus citations

• A phase i trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy

  Ramanathan, R. K., Stephenson, J. J., Weiss, G. J., Pestano, L. A., Lowe, A., Hiscox, A., Leos, R. A., Martin, J. C., Kirkpatrick, L. & Richards, D. A., Aug 2012, In: Investigational New Drugs. 30, 4, p. 1591-1596 6 p.

  Research output: Contribution to journal › Article › peer-review
  25 Scopus citations

• A phase i trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer

  Chiappori, A. A., Schreeder, M. T., Moezi, M. M., Stephenson, J. J., Blakely, J., Salgia, R., Chu, Q. S., Ross, H. J., Subramaniam, D. S., Schnyder, J. & Berger, M. S., Feb 28 2012, In: British journal of cancer. 106, 5, p. 839-845 7 p.

  Research output: Contribution to journal › Article › peer-review
  39 Scopus citations

• A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

  Bekaii-Saab, T. S., Roda, J. M., Guenterberg, K. D., Ramaswamy, B., Young, D. C., Ferketich, A. K., Lamb, T. A., Grever, M. R., Shapiro, C. L. & Carson, W. E., Nov 2009, In: Molecular cancer therapeutics. 8, 11, p. 2983-2991 9 p.

  Research output: Contribution to journal › Article › peer-review
  76 Scopus citations

• A phase I trial of MTA and gemcitabine in patients with locally advanced or metastatic cancer

  Adjei, A. A. & Erlichman, C., 1999, In: Seminars in oncology. 26, 2 SUUPL., p. 94-98 5 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study

  Fouladi, M., Perentesis, J. P., Phillips, C. L., Leary, S., Reid, J. M., Mcgovern, R. M., Ingle, A. M., Ahern, C. H., Ames, M. M., Houghton, P., Doyle, L. A., Weigel, B. & Blaney, S. M., Jul 2014, In: Pediatric Blood and Cancer. 61, 7, p. 1246-1251 6 p.

  Research output: Contribution to journal › Article › peer-review
  30 Scopus citations

• A phase i trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies

  Naing, A., Cohen, R., Dy, G. K., Hong, D. S., Dyster, L., Hangauer, D. G., Kwan, R., Fetterly, G., Kurzrock, R. & Adjei, A. A., Aug 2013, In: Investigational New Drugs. 31, 4, p. 967-973 7 p.

  Research output: Contribution to journal › Article › peer-review
  17 Scopus citations

• A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer

  Adjei, A. A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., Watanabe, T., Geary, R. S., Holmlund, J. & Dorr, F. A., Jan 1 2003, In: Clinical Cancer Research. 9, 1 I, p. 115-123 9 p.

  Research output: Contribution to journal › Article › peer-review
  79 Scopus citations

• A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu

  Peethambaram, P. P., Melisko, M. E., Rinn, K. J., Alberts, S. R., Provost, N. M., Jones, L. A., Sims, R. B., Lin, L. R. C., Frohlich, M. W. & Park, J. W., Sep 15 2009, In: Clinical Cancer Research. 15, 18, p. 5937-5944 8 p.

  Research output: Contribution to journal › Article › peer-review
  50 Scopus citations

• A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and ⁹⁰yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma

  Witzig, T. E., Wiseman, G. A., Maurer, M. J., Habermann, T. M., Micallef, I. N. M., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Link, B. K., Zent, C. S., Johnston, P. B., Shanafelt, T. D., Allmer, C., Asmann, Y. W., Gupta, M., Ballas, Z. K., Smith, B. J. & Weiner, G. J., Jul 2013, In: American journal of hematology. 88, 7, p. 589-593 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  22 Scopus citations

• A phase I trial of imetelstat in children with refractory or recurrent solid tumors: A children's oncology group phase I consortium study (ADVL1112)

  Thompson, P. A., Drissi, R., Muscal, J. A., Panditharatna, E., Fouladi, M., Ingle, A. M., Ahern, C. H., Reid, J. M., Lin, T., Weigel, B. J. & Blaney, S. M., Dec 1 2013, In: Clinical Cancer Research. 19, 23, p. 6578-6584 7 p.

  Research output: Contribution to journal › Article › peer-review
  40 Scopus citations

• A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma

  Witzig, T. E., Camoriano, J. K., Schroeder, G., Kurtin, P. J. & Habermann, T. M., Jan 1 1998, In: Leukemia and Lymphoma. 28, 3-4, p. 307-314 8 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer

  Dy, G. K., Mandrekar, S., Peethambaram, P. P., Okuno, S. H., Croghan, G. C., Hanson, L. J., Furth, A. & Adjei, A. A., Dec 2005, In: Cancer chemotherapy and pharmacology. 56, 6, p. 623-628 6 p.

  Research output: Contribution to journal › Article › peer-review
  7 Scopus citations

• A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer

  Trudel, S., Trachtenberg, J., Toi, A., Sweet, J., Li, Z. H., Jewett, M., Tshilias, J., Zhuang, L. H., Hitt, M., Wan, Y., Gauldie, J., Graham, F. L., Dancey, J. & Stewart, A. K., Oct 2003, In: Cancer Gene Therapy. 10, 10, p. 755-763 9 p.

  Research output: Contribution to journal › Article › peer-review
  49 Scopus citations

• A phase I trial of ad.hIFN-β gene therapy for glioma

  Chiocca, E. A., Smith, K. M., McKinney, B., Palmer, C. A., Rosenfeld, S., Lillehei, K., Hamilton, A., DeMasters, B. K., Judy, K. & Kirn, D., Mar 2008, In: Molecular Therapy. 16, 3, p. 618-626 9 p.

  Research output: Contribution to journal › Article › peer-review
  89 Scopus citations

• A phase I trial and pharmacokinetic study of aflibercept (VEGF trap) in children with refractory solid tumors: A Children's Oncology Group phase I consortium report

  Bender, J. G., Blaney, S. M., Borinstein, S., Reid, J. M., Baruchel, S., Ahern, C., Ingle, A. M., Yamashiro, D. J., Chen, A., Weigel, B., Adamson, P. C. & Park, J. R., Sep 15 2012, In: Clinical Cancer Research. 18, 18, p. 5081-5089 9 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy

  Huang, J., Campian, J. L., Gujar, A. D., Tran, D. D., Lockhart, A. C., DeWees, T. A., Tsien, C. I. & Kim, A. H., Jun 1 2016, In: Journal of neuro-oncology. 128, 2, p. 259-266 8 p.

  Research output: Contribution to journal › Article › peer-review
  33 Scopus citations

• A phase i study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m² administered weekly as a 30-minute intravenous infusion in patients with cancer

  Curtis, K. K., Hartney, J. T., Jewell, R. C., Park, J. W., Lebowitz, P. F., Griffin, P. P., Borad, M. J., Fitch, T. R. & Northfelt, D. W., Mar 1 2010, In: Journal of Clinical Pharmacology. 50, 3, p. 268-275 8 p.

  Research output: Contribution to journal › Article › peer-review
  7 Scopus citations

• A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

  Ailawadhi, S., Kelly, K. R., Vescio, R. A., Jagannath, S., Wolf, J., Gharibo, M., Sher, T., Bojanini, L., Kirby, M. & Chanan-Khan, A., Jan 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19, 1, p. 29-34 6 p.

  Research output: Contribution to journal › Article › peer-review
  26 Scopus citations

• A phase i study of vorinostat in combination with bortezomib in patients with advanced malignancies

  Schelman, W. R., Traynor, A. M., Holen, K. D., Kolesar, J. M., Attia, S., Hoang, T., Eickhoff, J., Jiang, Z., Alberti, D., Marnocha, R., Reid, J. M., Ames, M. M., McGovern, R. M., Espinoza-Delgado, I., Wright, J. J., Wilding, G. & Bailey, H. H., Dec 2013, In: Investigational New Drugs. 31, 6, p. 1539-1546 8 p.

  Research output: Contribution to journal › Article › peer-review
  23 Scopus citations

• A phase I study of topotecan and gemcitabine in advanced solid tumors

  Serna, D. S., Bekaii-Saab, T. & Kraut, E. H., Dec 1 2011, In: Investigational New Drugs. 29, 6, p. 1390-1394 5 p.

  Research output: Contribution to journal › Article › peer-review

• A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia

  Pratz, K. W., Rudek, M. A., Gojo, I., Litzow, M. R., McDevitt, M. A., Ji, J., Karnitz, L. M., Herman, J. G., Kinders, R. J., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Gladstone, D. E., Levis, M. J., Tsai, H. L., Rosner, G., Chen, A., Kaufmann, S. H. & Karp, J. E., Feb 15 2017, In: Clinical Cancer Research. 23, 4, p. 899-907 9 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix

  Kudelka, A. P., Levy, T., Verschraegen, C. F., Edwards, C. L., Piamsomboon, S., Termrungruanglert, W., Freedman, R. S., Kaplan, A. L., Kieback, D. G., Meyers, C. A., Jaeckle, K. A., Loyer, E., Steger, M., Mante, R., Mavligit, G., Killian, A., Tang, R. A., Gutterman, J. U. & Kavanagh, J. J., Sep 1997, In: Clinical Cancer Research. 3, 9, p. 1501-1505 5 p.

  Research output: Contribution to journal › Article › peer-review
  131 Scopus citations

• A phase I study of the vitamin D ₃ analogue ILX23-7553 administered orally to Patients with advanced solid tumors

  Jain, R. K., Trump, D. L., Egorin, M. J., Fernandez, M., Johnson, C. S. & Ramanathan, R. K., Dec 2011, In: Investigational New Drugs. 29, 6, p. 1420-1425 6 p.

  Research output: Contribution to journal › Article › peer-review
  13 Scopus citations

• A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors

  Zhu, M., Molina, J. R., Dy, G. K., Croghan, G. A., Qi, Y., Glockner, J., Hanson, L. J., Roos, M. M., Tan, A. D. & Adjei, A. A., Dec 1 2020, In: Investigational New Drugs. 38, 6, p. 1755-1762 8 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors

  Wang, F., Molina, J., Satele, D., Yin, J., Lim, V. S. & Adjei, A. A., Aug 15 2019, In: Investigational New Drugs. 37, 4, p. 658-665 8 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• APhase i study of the SMAC-mimetic birinapant in adults with refractory solid tumorsor lymphoma

  Amaravadi, R. K., Schilder, R. J., Martin, L. P., Levin, M., Graham, M. A., Weng, D. E. & Adjei, A. A., Nov 1 2015, In: Molecular cancer therapeutics. 14, 11, p. 2569-2575 7 p.

  Research output: Contribution to journal › Article › peer-review
  63 Scopus citations

• A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors

  Mody, K., Mansfield, A. S., Vemireddy, L., Nygren, P., Gulbo, J. & Borad, M., Aug 15 2019, In: Investigational New Drugs. 37, 4, p. 684-692 9 p.

  Research output: Contribution to journal › Article › peer-review
  8 Scopus citations

• A phase i study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

  Ganjoo, K. N., Cranmer, L. D., Butrynski, J. E., Rushing, D., Adkins, D., Okuno, S. H., Lorente, G., Kroll, S., Langmuir, V. K. & Chawla, S. P., Jun 1 2011, In: Oncology. 80, 1-2, p. 50-56 7 p.

  Research output: Contribution to journal › Article › peer-review
  57 Scopus citations

• A phase I study of the safety, Pharmacokinetics, and Pharmacodynamics of combination therapy with refametinib plus sorafenib in patients with advanced cancer

  Adjei, A. A., Richards, D. A., El-Khoueiry, A., Braiteh, F., Becerra, C. H. R., Jr, J. J. S., Hezel, A. F., Sherman, M., Garbo, L., Leffingwell, D. P., Iverson, C., Miner, J. N., Shen, Z., Yeh, L. T., Gunawan, S., Wilson, D. M., Manhard, K. J., Rajagopalan, P., Krissel, H. & Clendeninn, N. J., May 15 2016, In: Clinical Cancer Research. 22, 10, p. 2368-2376 9 p.

  Research output: Contribution to journal › Article › peer-review
  12 Scopus citations

• A phase i study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors

  Ngamphaiboon, N., Dy, G. K., Ma, W. W., Zhao, Y., Reungwetwattana, T., Depaolo, D., Ding, Y., Brady, W., Fetterly, G. & Adjei, A. A., Feb 2015, In: Investigational New Drugs. 33, 1, p. 225-232 8 p.

  Research output: Contribution to journal › Article › peer-review
  22 Scopus citations

• A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors

  Jazieh, K., Molina, J., Allred, J., Yin, J., Reid, J., Goetz, M., Lim, V. S., Kaufmann, S. H. & Adjei, A., Apr 15 2019, In: Investigational New Drugs. 37, 2, p. 307-314 8 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations